Treatment of Opioid Use Disorder Course: Criminal Justice Focus

Product not yet rated

  • Register
    • Non-Member - $99
    • Regular Member - $79
    • Retired - $79
    • Early Career Physician - $79
    • Resident - $79
    • Student - $79
    • Associate - $79
    • ASAM Staff - Free!
    • International Member - $79
    • Emeritus Member - $79
    • Provisional Member - $79
    • Fellow Member - $79
    • Honorary Member - $79
    • CRT Member - $79

image

Criminal Justice Focus

On-Demand Course

Overview

This 8-hour, on-demand course provides the education that is essential for providers to identify, assess, diagnose, and manage patients with opioid use disorder (OUD) in a justice-involved setting. The curriculum for this course has been specifically designed for providers treating patients in a justice-involved setting. It covers all medications and treatments for OUD and provides the required education needed to obtain the waiver to prescribe buprenorphine for over 30 patients.

The target audience for this introductory activity includes Physicians, Nurse Practitioners, Physician Assistants, Clinical Nurse Specialists, Certified Registered Nurse Anesthetists, and Certified Nurse Midwives seeking to treat opioid use disorder and prescribe buprenorphine in an office-based setting. All members of the healthcare team are encouraged to take the course.

This activity addresses the following ACGME Competencies: Patient Care, Medical Knowledge

Learning Objectives 

Upon completion, participants should be able to:  

  1. Identify, assess, and diagnose patients with opioid use disorder while considering severity, chronicity, individual characteristics, and psychiatric and medical comorbidities. 
  2. Understand addiction as a chronic disease involving complex interactions among brain circuits, genetics, the environment, and an individual's life experiences. 
  3. Follow ASAM Levels of Care to develop an individualized, patient-centered treatment plan, including negotiating treatment goals by evaluating appropriate medication- and psychosocial-based treatment options.  
  4. Monitor progress and modify treatment plans based on patient needs and progress toward treatment goals.  
  5. Implement best practices for office systems, including team-based care, to support treatment with medications for opioid use disorder. 
  6. Examine misconceptions, stigma, and complexities (bioethical, social, clinical, and public health) associated with opioid use disorder and the use of medications to treat opioid use disorder. 

Registration Rates

ASAM Learner TypeRate
ASAM Member$79
Non- Member$99
Associate Member$79
Resident Member$79
Student Member$79

*Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.

Membership Question?  Call ASAM at 1.301.656.3920, email us, or view the ASAM website for more information.

Refunds & Cancellations

All ASAM e-Learning Center refund requests must be made in writing to Education@asam.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.

Registration Deadline: 09/06/2024

This content has been made available in part by a small unrestricted educational grant from Indivior, Inc. No input or influence from Indivior, was included in the development of the educational content. As an ACCME Provider, ASAM follows the ACCME Standards for Integrity and Independence for Accredited Continuing Education stating that owners and employees of ineligible companies are excluded from participating as planners or faculty, and must not be allowed to influence or control any aspect of the planning, delivery, or evaluation of accredited continuing education. 

Instructions

  1. Click on the Contents tab to begin this activity.
  2. Click Complete Post Test after each module to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 4 out of 5 questions correctly.
  3. Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
  4. Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM e-Learning Center, clicking Dashboard, and clicking Transcript/Achievements.

Need Assistance?

For assistance logging in, accessing activities, claiming credit, or for other questions or concerns, please check the FAQ page or e-mail Education@ASAM.org

ASAM is proud to offer eSSENTIAL Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.

Daniel P. Alford

MD, MPH, FACP, DFASAM

Daniel Alford, MD, MPH, FACP, DFASAM is a Professor of Medicine and Associate Dean of Continuing Medical Education at Boston University School of Medicine (BUSM). He is on staff in the Section of General Internal Medicine and Director of the Clinical Addiction Research and Education (CARE) Unit at Boston Medical Center. He is the Medical Director of the CDC-funded Boston Sustainable Models for unhealthy Alcohol use ReducTion (B SMART) and the HRSA funded SBIRT And FASD Education, Support and Treatment (SAFEST) Choice programs. 

No relevant financial disclosures

John Chardavoyne

MD

Dr. John Chardavoyne is a Psychiatrist and the Medical Director of Bright Heart Health, a Telehealth organization that offers treatment services to individuals with substance use disorders, psychiatric illness (including eating disorders), and chronic pain. Most recently, he acted as Interim Chief Medical Officer of Stonington Institute, Director of Medical Services at the Stonington Institute Partial Hospital/IOP Recovery Program, and Medical Director of Outpatient Medical Services at Stonington Institute. He has held leadership and management positions, supervised healthcare professionals in various settings, and taught in medical schools to national conferences. He has undergone specialized psychotherapy training in Transference Focused Psychotherapy, Dialectical Behavior Therapy, and treating people with Dissociative Identity Disorder and other chronic dissociative processes. Dr. Chardavoyne's expertise is treating adults who endured significant and sustained childhood trauma that resulted in Substance Use Disorders, Personality Disorders, Dissociative Disorders, Complex PTSD, and Mood Disorders. In 2013, the Connecticut Psychiatric Society awarded him the Roger Coleman Memorial Award Service to Patients for responding after the Sandy Hook tragedy.

No relevant financial disclosures

Joseph F. Gerstein

MD, FACP

Dr. Joe Gerstein retired as a Clinical Assistant Professor of Medicine at Harvard Medical School. He spent 30 years in the practice of Internal Medicine and Pain Management. He is one of the founders of SMART Recovery Mutual Aid Network, 501c3 [Self-Management Addiction Recovery Training], an Evidence-based Program now with 3,500 free meetings in 33 countries. As a volunteer, he has facilitated over 3,200 SMART meetings, almost 800 in prisons and jails. He instigated NIDA to fund the development of the 24-meeting Correctional Version of the SMART Recovery Program: "InsideOut," now in use in about 300 prisons and jails globally. This is now available in 12-meeting condensations for jails and reentry programs. Dr. Gerstein authored the chapter on "Alternatives to the 12-Step Programs" in the 2nd Edition of the ASAM TEXTBOOK OF ADDICTION MEDICINE. He is now a Co-Chair of the ASAM SIG on Criminal Justice.



John Chardavoyne, MD


Dr. John Chardavoyne is a Psychiatrist and the Medical Director of Bright Heart Health, a Telehealth organization that offers treatment services to individuals with substance use disorders, psychiatric illness (including eating disorders), and chronic pain. Most recently, he acted as Interim Chief Medical Officer of Stonington Institute, Director of Medical Services at the Stonington Institute Partial Hospital/IOP Recovery Program, and Medical Director of Outpatient Medical Services at Stonington Institute. He has held leadership and management positions, supervised healthcare professionals in various settings, and taught in medical schools to national conferences. He has undergone specialized psychotherapy training in Transference Focused Psychotherapy, Dialectical Behavior Therapy, and treating people with Dissociative Identity Disorder and other chronic dissociative processes. Dr. Chardavoyne's expertise is treating adults who endured significant and sustained childhood trauma that resulted in Substance Use Disorders, Personality Disorders, Dissociative Disorders, Complex PTSD, and Mood Disorders. In 2013, the Connecticut Psychiatric Society awarded him the Roger Coleman Memorial Award Service to Patients for responding after the Sandy Hook tragedy.


No relevant financial disclosures

Carolyn McIlree

MD, MPH, FASAM

Dr. Carolyn McIlree is an Addiction Medicine Physician and Sponsor for the Baltimore Pre-Trial Complex Opioid Treatment Programs. She is board-certified in Addiction Medicine and Public Health & General Preventive Medicine. Dr. McIlree attended college at Stony Brook University and obtained a master’s degree in Psychology, where she studied working memory using functional magnetic resonance imaging (fMRI). She earned her medical degree from the University of Vermont College of Medicine and completed residency training in Public Health & General Preventive Medicine at the University of Maryland Baltimore with an MPH in Epidemiology. Dr. McIlree served as House Staff Officer for Quality Improvement & Patient Safety while a resident and completed Addiction Medicine Fellowship training at Caron Treatment Centers & Tower Health System's Reading Hospital. Dr. McIlree has an interest in continuous quality improvement techniques to improve health care delivery and is currently pursuing Lean Six Sigma Greenbelt certification. She is closely involved with implementation of House Bill 116 in the Baltimore Pre-Trial Complex, which establishes programs of screening, evaluation, and treatment of Opioid Use Disorder in local correctional facilities.

No relevant financial disclosures

Debra Newman

PA-C, MPAS, MPH

Debra R. Newman, PA-C, MPAS, MPH is a Treatment Provider for Adult Drug/Mental Health Treatment Courts. She has worked in detox/residential treatment, outpatient addiction medicine, and adult psychiatry. Her passion for addiction medicine began with her association with Project ECHO in 2008. While employed at an FQHC in northern NM in a region historically plagued with the highest per capita heroin death rate in the nation, Debra worked under an addiction medicine psychiatrist and several family practice physicians waivered to prescribe buprenorphine. For over four years, she managed over 200 buprenorphine patients monthly, as the only full-time provider for these patients, while also carrying a caseload of HCV and chronic pain patients. She is currently the Assistant Editor for ASAM Weekly.

No relevant financial disclosures

Yngvild K. Olsen

MD, MPH, DFASAM

Yngvild K. Olsen, MD, MPH, DFASAM graduated from Harvard Medical School in 1997, from the residency training program in internal medicine at Boston Medical Center in 2000, and from the Fellowship in General Internal Medicine at the Johns Hopkins School of Medicine in 2001. Dr. Olsen also serves as the Medical Director of the Institutes for Behavior Resources Inc/REACH Health Services in Baltimore City. Dr. Olsen currently serves as Vice President of the American Society of Addiction Medicine and is a member of the Public Policy Committee. She is the Immediate Past President of the Maryland Society of Addiction Medicine, Immediate Past President of the Maryland Association for the Treatment of Opioid Dependence, and a Board member of the National Council on Alcoholism and Drug Dependence-MD (NCADD-MD). 

No relevant financial disclosures

Edwin Salsitz

MD, DFASAM

Edwin Salsitz, MD, DFASAM has been an attending physician at Mt. Sinai Beth Israel, Division of Chemical Dependency, in New York City since 1983, and is an Associate Professor of Medicine at the Icahn School of Medicine at Mount Sinai. He is the principal investigator of the Methadone Medical Maintenance (office-based methadone maintenance) research project. Dr. Salsitz is certified by the American Board of Addiction Medicine (ABAM), as well as by the Board of Internal Medicine and Pulmonary Disease. He has published and lectures frequently on addiction medicine topics. 

Dr. Salsitz is Curriculum Director for The ASAM Treatment of Opioid Use Disorder Course and is a mentor in the PCSS-MAT mentoring program. He has co-chaired The ASAM Review Course, The ASAM Pain & Addiction: Common Threads Course, The ASAM State of the Art Course in Addiction Medicine and is a reviewer for the Journal of Addiction Medicine. He is the chair of The CO*RE/ASAM Opioid Prescribing: Safe Practice, Changing Lives Course. 

He is a member of the ASAM Medical Education Council and the ASAM CME Committee and is Chair of the New York Society of Addiction Medicine CME and Education Committees. Dr. Salsitz is a member of the medical advisory panel for the New York State Office of Alcohol and Substance Abuse Services. He is the recipient of the 2014 ASAM Annual Award and the 2018 ASAM Educator of the Year Award.

No relevant financial disclosures

Kristin Smith

DNP, FNP-C

Kristin Smith graduated from St. John Fisher’s FNP/DNP program in May 2013. She is a staff clinician and the Program Director of a Nurse Practitioner (NP) Residency Program at Highland Family Medicine, where she provides Medication Assisted Treatment (MATx) in both dedicated suboxone clinics as well as integrated primary care settings. Dr. Smith is also a certified American Academy of HIV Medicine Specialist with experience providing HIV care and Pre/Post-Exposure prophylaxis. Prior to transitioning to her current role, she served as the Clinical Director of an Opioid Overdose Prevention Program, where she became passionate about harm reduction while providing community training on Naloxone, teaching safe injection practices, and providing needle exchange services in collaboration with a team of individuals through Trillium Health.

No relevant financial disclosures

Bernard Stuetz

PA-C, MA

Bernard Stuetz, PA-C, MA is the Past President of the Society of Physician Assistants in Addiction Medicine and currently acting as Chief Delegate to the American Academy of PAs (AAPA) House of Delegates (HOD). He is also the Director for Federal Affairs. He has been a delegate to the AAPA HOD for 31 years. He was a member of the AAPA Recertification Committee in 2012, during which he recommended changes to the ten-year cycle requirements. As a delegate in the AAPA HOD, he was the lead advocate to change the re-certification cycle from six to ten years. He was the first PA to work in the White House on Health Care Policy from 1993 to 1995. Having practiced Addiction Medicine for 25 years, Mr. Stuetz currently works in an OTP and Buprenorphine practice.

No relevant financial disclosures

Matthew Tierney

APRN

Matt Tierney, APRN is a Nurse Practitioner and a Clinical Professor at the UCSF School of Nursing. He also serves as Clinical Director of Substance Use Treatment and Education for the Office of Population Health at UCSF Health. The focus of his career has been on improving essential addiction treatment delivery locally, regionally, and nationally. He is a Fellow of the American Academy of Nursing, where he serves on the Expert Panel on Psychiatric-Mental Health and Substance Use. Matt is also President-Elect of the American Psychiatric Nurses Association and represents APNA as a sponsoring member of the National Academies of Science Engineering and Medicine's Forum of Mental Health and Substance Use Disorders. He is an ASAM member who has been teaching waiver training courses since 2008. He has treated over 1,600 patients with buprenorphine and has worked in licensed Opiate Treatment programs providing all three FDA-approved medications for OUD treatment.

No relevant financial disclosures

J. Deanna Wilson

MD, MPH

Dr. Deanna Wilson is an Assistant Professor of Medicine and Pediatrics at the University of Pittsburgh School of Medicine. She received her MD from Yale University School of Medicine and trained in internal medicine and pediatrics at the Johns Hopkins University School of Medicine. She completed additional subspecialty training in both adolescent and addiction medicine also at Johns Hopkins. She currently sees patients at UPMC’s Center for Opioid Recovery, a Pennsylvania Center of Excellence. She provides inpatient addiction medicine consultation to patients hospitalized at UPMC Presbyterian Hospital and is Medical Director for the Center for Adolescent and Young Adult Recovery and Empowerment. 

She has expertise in integrating harm reduction, substance use treatment, and primary care into clinical practice. Her current research interests are in the design and evaluation of interventions to engage and retain hospitalized young adults who inject drugs into substance use treatment. She leverages health services research, implementation science, and community engaged methods to improve health equity for vulnerable populations who use substances. 

No relevant financial disclosures

Melissa Weimer

DO, MCR, DFASAM

Melissa Weimer, DO, MCR, DFASAM is board-certified in Internal Medicine and Addiction Medicine and an Assistant Professor of Medicine at Yale University School of Medicine. At Yale, she also serves as the Medical Director of the Yale Addiction Medicine Consult Service and Associate Program Director of the Addiction Medicine Fellowship Program. Dr. Weimer has a clinical and research focus on expanding access to treatment for patients with substance use disorders, particularly in the hospital setting. She also has fellowship training and years of experience in the management of complex pain, particularly for patients with concomitant opioid use disorders.

No relevant financial disclosures

CME, CE, CEU and other Credit Types

ACCME Accredited with Commendation

ACCME Accreditation Statement 

The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Society of Addiction Medicine designates this live activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NAADAC, the Association for Addiction Professionals

This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

California Association for Drug/Alcohol Educators (CAADE)

This educational program is approved by CAADE: #CP40 999 1222

California Association of DUI Treatment Centers (CADTP)

This educational program is approved by CADTP: #205

California Consortium of Addiction Programs and Professionals (CCAPP)

This educational program is approved by CCAPP: #OS-20-330-1222

Continuing Education Credits (CEUs)

Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

Maintenance of Certification (MOC) or Continuing Certification Programs (CCP)

American Board of Preventive Medicine (ABPM)

The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 8 LLSA credit towards ABPM MOC Part II requirements.

American Board of Anesthesiology (ABA)

This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

American Board of Pediatrics (ABP)

Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 8 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

American Board of Internal Medicine (ABIM)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.

American Board of Surgery (ABS)

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and/or Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

American Board of Psychiatry and Neurology (ABPN)

Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

American Board of Addiction Medicine (ABAM)

Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

Royal College of Physicians and Surgeons of Canada (RCPSC)

Royal College Fellows can use participation in Accredited Continuing Medical Education to earn Section 3 Credits

Disclosure Information

In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships for the Planning Committees and Presenters. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

Key:

Complete
Failed
Available
Locked
Complete Course Overview
Begin self-paced component package.
Begin self-paced component package. This activity will take 30 minutes to complete. This activity was last reviewed and updated in September 2021.
Module 1 - Identifying, Assessing, and Diagnosing Patients with Opioid Use Disorder
Complete Module 1
Begin self-paced component package.
Begin self-paced component package. This activity will take 60 minutes to complete. This activity was last reviewed and updated in September 2021.
Complete Post Test - Module 1
5 Questions  |  10 attempts  |  4/5 points to pass
5 Questions  |  10 attempts  |  4/5 points to pass This post-test has 5 questions and requires 4 out of 5 questions to pass the test.
Module 2 - Determining Treatment Plan for Patients with Opioid Use Disorder
Complete Module 2
Begin self-paced component package.
Begin self-paced component package. This activity will take 90 minutes to complete. This activity was last reviewed and updated in September 2021.
Complete Post Test - Module 2
4 Questions  |  10 attempts  |  3/4 points to pass
4 Questions  |  10 attempts  |  3/4 points to pass This post-test has 4 questions and requires 3 out of 4 questions to pass the test.
Module 3 - Implementing Office-Based Opioid Treatment
Complete Module 3
Begin self-paced component package.
Begin self-paced component package. This activity will take 90 minutes to complete. This activity was last reviewed and updated in September 2021.
Complete Post Test - Module 3
5 Questions  |  10 attempts  |  4/5 points to pass
5 Questions  |  10 attempts  |  4/5 points to pass This post-test has questions and requires 4 out of 5 questions to pass the test.
Module 4 - Special Populations
Complete Module 4
Begin self-paced component package.
Begin self-paced component package. This activity will take 120 minutes to complete. This activity was last reviewed and updated in September 2021.
Complete Post Test - Module 4
5 Questions  |  10 attempts  |  4/5 points to pass
5 Questions  |  10 attempts  |  4/5 points to pass This post-test has 5 questions and requires 4 out of 5 questions to pass the test.
Module 5 - Keeping Your Patient Safe
Complete Module 5
Begin self-paced component package.
Begin self-paced component package. This activity will take 90 minutes to complete. This activity was last reviewed and updated in September 2021.
Complete Post Test - Module 5
5 Questions  |  10 attempts  |  4/5 points to pass
5 Questions  |  10 attempts  |  4/5 points to pass This post-test has 5 questions and requires 4 out of 5 questions to pass the test.
Evaluation & Credit
Complete Evaluation
16 Questions
16 Questions Scroll down on evaluation, there may be questions that expand past the size of the window.
Claim Credit & Certificate
Up to 8.00 medical credits available  |  Certificate available
Up to 8.00 medical credits available  |  Certificate available Participants should claim only the credit commensurate with the extent of their participation in the activity.
Open Waiver Application
Select the "Go To Application Site" button to begin.
Select the "Go To Application Site" button to begin. Click to open the waiver application on SAMHSA's website. You must upload a copy of your CME certificate to submit your application.